Related News

May 6, 2020

SmarTrend's candlestick scanner has spotted a possible bullish inside day candle pattern in Supernus Pharmac (NASDAQ:SUPN) based on the price action in the company's shares. Yesterday's price range of $22.17 and...

May 4, 2020

SmarTrend identified an Uptrend for Supernus Pharmac (NASDAQ:SUPN) on April 7th, 2020 at $18.43. In approximately 4 weeks, Supernus Pharmac has returned 20.89% as of today's recent price of $22.28.

In the...

April 11, 2020

Below are the three companies in the Pharmaceuticals industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Allergan Plc ranks...

April 4, 2020

Below are the three companies in the Pharmaceuticals industry with the highest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and...

April 2, 2020

Below are the three companies in the Pharmaceuticals industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

April 2, 2020

Below are the three companies in the Pharmaceuticals industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

March 31, 2020

Below are the three companies in the Pharmaceuticals industry with the highest year-over-year expected earnings per share (EPS) growth rates.

Horizon Pharma P ranks highest with a EPS growth of 38,527.3%. Following is Pacira Pharmaceu...

March 27, 2020

Below are the three companies in the Pharmaceuticals industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns.

...

March 20, 2020

Supernus Pharmac (NASDAQ:SUPN) shares have crossed bullishly above their 10-day moving average of $15.65 on a volume of 171K shares. This may provide swing traders with an opportunity for a long position, as such...

March 18, 2020

SmarTrend identified a Downtrend for Supernus Pharmac (NASDAQ:SUPN) on November 6th, 2019 at $20.68. In approximately 4 months, Supernus Pharmac has returned 32.24% as of today's recent price of $14.01.

In...